MAMLCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。MAML遺伝子サイレンサーは、MAML CRISPR/Cas9ノックアウトプラスミドとMAMLDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のMAMLCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
MAML CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
MAML2 CRISPR/Cas9 KOプラスミド (h) | sc-409346 | h | Gene Knockout | GFP | 0 | ||
MAML2 HDRプラスミド (h) | sc-409346-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
MAML2 Double Nickaseプラスミド (h) | sc-409346-NIC | h | Gene Knockout | Puromycin | 0 | ||
MAML2 Double Nickaseプラスミド (h2) | sc-409346-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
MAML2 CRISPR/Cas9 KOプラスミド (m) | sc-435408 | m | Gene Knockout | GFP | 0 | ||
MAML2 HDRプラスミド (m) | sc-435408-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
MAML2 Double Nickaseプラスミド (m) | sc-435408-NIC | m | Gene Knockout | Puromycin | 0 | ||
MAML2 Double Nickaseプラスミド (m2) | sc-435408-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
MAML3 CRISPR/Cas9 KOプラスミド (h) | sc-412545 | h | Gene Knockout | GFP | 0 | ||
MAML3 HDRプラスミド (h) | sc-412545-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
MAML3 Double Nickaseプラスミド (h) | sc-412545-NIC | h | Gene Knockout | Puromycin | 0 | ||
MAML3 Double Nickaseプラスミド (h2) | sc-412545-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
MAML3 CRISPR/Cas9 KOプラスミド (m) | sc-436639 | m | Gene Knockout | GFP | 0 | ||
MAML3 HDRプラスミド (m) | sc-436639-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
MAML3 Double Nickaseプラスミド (m) | sc-436639-NIC | m | Gene Knockout | Puromycin | 0 | ||
MAML3 Double Nickaseプラスミド (m2) | sc-436639-NIC-2 | m | Gene Knockout | Puromycin | 0 |
MAML CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
MAML2 CRISPR Activationプラスミド (h) | sc-409346-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MAML2 CRISPR Activationプラスミド (h2) | sc-409346-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MAML2 Lentiviral Activation Particles (h) | sc-409346-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MAML2 Lentiviral Activation Particles (h2) | sc-409346-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MAML2 CRISPR Activationプラスミド (m) | sc-435408-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MAML2 CRISPR Activationプラスミド (m2) | sc-435408-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MAML2 Lentiviral Activation Particles (m) | sc-435408-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MAML2 Lentiviral Activation Particles (m2) | sc-435408-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MAML3 CRISPR Activationプラスミド (h) | sc-412545-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MAML3 CRISPR Activationプラスミド (h2) | sc-412545-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MAML3 Lentiviral Activation Particles (h) | sc-412545-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MAML3 Lentiviral Activation Particles (h2) | sc-412545-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MAML3 CRISPR Activationプラスミド (m) | sc-436639-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MAML3 CRISPR Activationプラスミド (m2) | sc-436639-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MAML3 Lentiviral Activation Particles (m) | sc-436639-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MAML3 Lentiviral Activation Particles (m2) | sc-436639-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |